Literature DB >> 24986043

Rare association of pyoderma gangrenosum and palmoplantar pustulosis: a case report and review of the previous works.

Mikio Ohtsuka1, Toshiyuki Yamamoto.   

Abstract

Pyoderma gangrenosum is a rare inflammatory, ulcerative skin disease that mainly involves the lower extremities. It frequently occurs in association with systemic diseases such as inflammatory bowel disease, myeloproliferative disorders and rheumatoid arthritis. Palmoplantar pustulosis is also an inflammatory dermatosis characterized by recurrent sterile pustules localized on the palms and soles. These two dermatoses are histologically characterized by neutrophilic infiltration into the lesional skin. Co-occurrence of pyoderma gangrenosum and palmoplantar pustulosis in a single patient is extremely rare. We report a case of pyoderma gangrenosum occurred in a patient with palmoplantar pustulosis, with a review of the previously reported cases. A 68-year-old Japanese woman with a 10-year history of palmoplantar pustulosis developed a skin ulcer on the left lower leg. The ulcer was diagnosed as pyoderma gangrenosum based on the clinical and histological findings, and rapidly improved in response to oral prednisolone. In addition to our case, five cases with palmoplantar pustulosis who developed pyoderma gangrenosum have been reported. These cases were thought to have some characteristics in common, such as marked female predominance, no association with inflammatory bowel disease and myeloproliferative disorders, and good response to less aggressive therapy. The co-occurrence of pyoderma gangrenosum and palmoplantar pustulosis in our case may have an etiological link, rather than being a coincidental complication.
© 2014 Japanese Dermatological Association.

Entities:  

Keywords:  T-helper 17; interleukin-17; palmoplantar pustulosis; pyoderma gangrenosum; tumor necrosis factor-α

Mesh:

Substances:

Year:  2014        PMID: 24986043     DOI: 10.1111/1346-8138.12543

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  3 in total

Review 1.  Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases.

Authors:  Agnieszka Wasilewska; Marta Winiarska; Małgorzata Olszewska; Lidia Rudnicka
Journal:  Postepy Dermatol Alergol       Date:  2016-08-16       Impact factor: 1.837

2.  Simultaneous occurrence of Pyoderma Gangrenosum and Palmoplantar Pustular Psoriasis: Is it an association or coincidental findings?

Authors:  Chapagain Pukar; Agrawal Sudha; Paudyal Punam
Journal:  Clin Case Rep       Date:  2020-11-18

3.  Successful Treatment of a Patient with Pyoderma Gangrenosum, Plaque Psoriasis and Palmoplantar Pustulosis with Adalimumab.

Authors:  Yuqi Chu; Taoming Liu; Juan Bai; Hong Fang; Jianjun Qiao
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-09-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.